Intelligence Platform
Patents
Browse 73 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10786566
Stable aqueous formulations of adalimumab
granted patentUS 10780163
Stable aqueous formulations of adalimumab
granted patentUS 10772865
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted patentUS 10772959
Stable aqueous formulations of adalimumab
granted patentUS 10772960
Stable aqueous formulations of adalimumab
granted patentUS 10772963
Etanercept formulations stabilized with xylitol
granted patentUS 10722579
Stable aqueous formulations of adalimumab
granted patentUS 10716852
Stable aqueous formulations of adalimumab
granted patentUS 10716853
Stable aqueous formulations of adalimumab
granted patentUS 10716854
Stable aqueous formulations of adalimumab
granted patentUS 10688183
Stable aqueous formulations of adalimumab
granted patentUS 10555929
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted patentUS 10493151
Etanercept formulations stabilized with sodium chloride
granted patentUS 10485869
Etanercept formulations stabilized with meglumine
granted patentUS 10376588
Etanercept formulations stabilized with combinations of sugars and polyols
granted patentUS 10293049
Etanercept formulations stabilized with amino acids
granted patentUS 10286072
Methods of manufacturing stable aqueous formulations of adalimumab
granted patentUS 10286071
Syringe containing stable aqueous formulations of adalimumab
granted patentUS 10213508
Etanercept formulations stabilized with xylitol
granted patentUS 10207000
Stable aqueous formulations of adalimumab
granted patentUS 10195275
Stable aqueous formulations of adalimumab
granted patentUS 10159732
Stable aqueous formulations of adalimumab
granted patentUS 10159733
Stable aqueous formulations of adalimumab
granted patentUS 10155039
Stable aqueous formulations of adalimumab
granted